Home › Crohn's Disease › Washington › Bellevue
Crohn's Disease clinical trials in Bellevue, WA
4 studies for Crohn's Disease are looking for participants at sites in and around Bellevue (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
RecruitingPhase 4
- GI Alliance, Bellevue
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RecruitingPhase 2
- Washington Gastroenterology - Bellevue /ID# 283966, Bellevue
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- GI Alliance - Bellevue-Site Number: 8400143, Bellevue
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
RecruitingPhase 2
- Mirador Therapeutics Selected Site, Bellevue
About Crohn's Disease
Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.
More about Crohn's Disease on MedlinePlus
Crohn's Disease trials in other cities
- New York City, NY33 studies
- St. Louis, MO19 studies
- Miami, FL19 studies
- Orlando, FL19 studies
- Boston, MA18 studies
- Houston, TX17 studies
- Atlanta, GA16 studies
- Tyler, TX16 studies
- San Diego, CA15 studies
- Cleveland, OH15 studies
- Colorado Springs, CO14 studies
- San Antonio, TX14 studies
Other studies in Bellevue
- Major Depressive Disorder9 studies
- Ulcerative Colitis6 studies
- Depression5 studies
- Alzheimer's Disease5 studies
- Schizophrenia5 studies
- Bipolar Disorder4 studies
- Knee Osteoarthritis4 studies
- Breast Cancer3 studies
- Psychotic Disorders3 studies
- Obesity3 studies
- Generalized Anxiety Disorder3 studies
- Steatotic Liver Disease3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.